Loading...

Reset Password

NDAR provides a single access to de-identified autism research data. For permission to download data, you will need an NDAR account with approved access to NDAR or a connected repository (AGRE, IAN, or the ATP). For NDAR access, you need to be a research investigator sponsored by an NIH recognized institution with federal wide assurance. See Request Access for more information.

Warning Notice

This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action.

All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.

You have logged in with a temporary password. Please update your password. Passwords must contain 8 or more characters and must contain at least 3 of the following types of characters:

Subscribe to our mailing list

Mailing List(s)
Email Format

You are now leaving the National Database for Autism Research (NDAR) web site to go to:

Click on the address above if the page does not change within 10 seconds.

Disclaimer

NDAR is not responsible for the content of this external site and does not monitor other web sites for accuracy.

Selected Filters
No filters selected

The filters you have selected from various query interfaces will be stored here, in the 'Filter Cart'. The database will be queried using filters added to your 'Filter Cart', when multiple filters are defined, each will be executed using 'AND' logic, so with each filter that is applied the result set gets smaller.

From the 'Filter Cart' you can inspect each of the filters that have been defined, and you also have the option to remove filters. The 'Filter Cart' itself will display the number of filters applied along with the number of subjects that are identified by the combination of those filters. For example a GUID filter with two subjects, followed by a GUID filter for just one of those subjects would return only data for the subject that is in both GUID filters.

If you have a question about the filter cart, or underlying filters please contact the help desk at The NDA Help Desk

Description
Value Range
Notes
Data Structures with shared data
No filters have been selected

Clinic Visit

ccv

01

Download Definition as
Download Submission Template as
Element NameData TypeSizeRequiredDescriptionValue RangeNotesAliases
subjectkeyGUIDRequiredThe NDAR Global Unique Identifier (GUID) for research subjectNDAR*
src_subject_idString20RequiredSubject ID how it's defined in lab/projectbid, id, randid
interview_dateDateRequiredDate on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYYYRequired field
interview_ageIntegerRequiredAge in months at the time of the interview/test/sampling/imaging.0 :: 1260Age is rounded to chronological month. If the research participant is 15-days-old at time of interview, the appropriate value would be 0 months. If the participant is 16-days-old, the value would be 1 month.
genderString20RequiredSex of the subjectM;FM = Male; F = Female
levelString10RecommendedTreatment level
weekFloatRecommendedWeek in level/study99=week 10-week 14
crcidString40RecommendedCRC ID/ROA ID
clinidIntegerRecommendedClinician ID
clinicidIntegerRecommendedClinic ID
updateIntegerRecommendedUpdated form0;11=Updated
vis_typeIntegerRecommendedVisit type0::21=Phone; 0=doctor's office; 2=No, not phone interviewlocale, phone
menopIntegerRecommendedMenopausal/post-hysterectomy/male0;10=No; 1=Yes
mpdatmIntegerRecommendedDate of last menstrual periodmpdate
medication1_nameString100RecommendedName first medication that the participant has taken999= Legitimately skipped;admd1, llaa3a, stnm1
medication2_nameString100RecommendedName second medication that the participant has taken999= Legitimately skipped;admd2, llaa3b, stnm2
medication3_nameString150RecommendedName third medication that the participant has taken999= Legitimately skipped;admd3, llaa3c, stnm3
medication4_nameString100RecommendedName fourth medication that the participant has taken999= Legitimately skipped;admd4, llaa3d, llaada, stnm4
medication1_dosageString50RecommendedFirst medication dosageadds1, llaa4a1
medication2_dosageString50RecommendedSecond medication dosageadds2, llaa4b1
medication3_dosageString50RecommendedThird medication dosageadds3, llaa4c1
medication4_dosageString50RecommendedFourth medication dosageadds4, llaa4d1
lithmIntegerRecommendedPatient taking Li/NTP0;10=No; 1=Yes
mtypeIntegerRecommendedMed type1::41=Li; 2=NTP; 3 = Other psychiatric medication, 4 = Non-psychiatric medication
serumFloatRecommendedMost recent serum level
drdatIntegerRecommendedDate blood drawn
liadjIntegerRecommendedLi or NTP dose adjustment needed0;1;-20=No; 1=Yes; -2=N/A
litdyIntegerRecommendedLi or NTP serum level needed today0;1;-20=No; 1=Yes; -2=N/A
suicdIntegerRecommendedPatient presently a suicide risk0;10=No; 1=Yesrisksui, risksuic
remsnIntegerRecommendedPatient in remission0;10=No; 1=Yes
raiseIntegerRecommendedDose will be raised0;10=No; 1=Yes
effctIntegerRecommendedSide effects prevent dose increase0;10=Not checked; 1=Checkedsideefct
cnmdIntegerRecommendedConcomitant meds prevent dose increase0;10=Not checked; 1=Checked
cncnIntegerRecommendedMedical condition prevents dose increase0;10=Not checked; 1=Checked
prtclIntegerRecommendedProtocol prohibits dose increase0;10=Not checked; 1=Checked
otherIntegerRequiredOther::0;1;9990 = No; 1 = Yes
stmedIntegerRecommendedCurrently on STAR*D meds?0;10=No; 1=Yes
stmd1String100RecommendedPrescribed med code 1
stmd2String50RecommendedPrescribed med code 2
stmd3String50RecommendedPrescribed med code 3
stmd4String50RecommendedPrescribed med code 4
stmd5String50RecommendedPrescribed med code 5
stmd6String50RecommendedPrescribed med code 6
stds1FloatRecommendedPrescribed med daily dose 1
stds2FloatRecommendedPrescribed med daily dose 2
stds3FloatRecommendedPrescribed med daily dose 3
stds4FloatRecommendedPrescribed med daily dose 4
stds5String50RecommendedPrescribed med daily dose 5
stds6String50RecommendedPrescribed med daily dose 6
adstart1IntegerRecommendedStudy med start date at this dose 1
adstart2IntegerRecommendedStudy med start date at this dose 2
adstart3IntegerRecommendedStudy med start date at this dose 3
adstart4IntegerRecommendedStudy med start date at this dose 4
stsd1FloatRecommendedPrescribed med start date 1
stpdate1FloatRecommendedStudy med stop date1sted1
stsd2FloatRecommendedPrescribed med start date 2
stpdate2FloatRecommendedStudy med stop date2sted2
stsd3FloatRecommendedPrescribed med start date 3
stpdate3FloatRecommendedStudy med stop date3sted3
stsd4FloatRecommendedPrescribed med start date 4
stpdate4FloatRecommendedStudy med stop date4sted4
stsd5IntegerRecommendedPrescribed med start date 5
stpdate5IntegerRecommendedPrescribed med end date 5sted5
stsd6IntegerRecommendedPrescribed med start date 6
stpdate6IntegerRecommendedPrescribed med end date 6sted6
trtmtIntegerRecommendedTreatment plan1::41=Continue current level; 2=Go to next level; 3=Go to follow up; 4=Exit study
fnaidIntegerRecommendedBilled to third party0;10=No; 1=Yes
days_baselineIntegerRecommendedDays since baselinedate
visitString50RecommendedVisit nameCharacter description of each type of visitint1, vtype
uvfa1aIntegerRecommendedWhy did this visit occur:Assessment of possible change in psychiatric symptoms?0;10=No; 1=Yes
uvfa1bIntegerRecommendedWhy did this visit occur: Assessment of possible change in drug tolerability, adverse event?0;10=No; 1=Yes
uvfa1cIntegerRecommendedWhy did this visit occur: Assessment of possible change in medical status.0;10=No; 1=Yes
uvfa1dIntegerRecommendedWhy did this visit occur: Assessment of need for medication changes or adjustment or re-supply.0;10=No; 1=Yes
fseqnoIntegerRecommendedSequence Number0::999The FSEQNO variable in the ADJ form has a special interpretation compared to other forms. For example, ADJ FSEQNO of '1' can be thought of as being '001', FSEQNO of '2' can be thought of as being '002', and FSEQNO of '3' can be thought of as being '003'. The first digit of FSEQNO relates to the corresponding ENF sequence number at that visit and the third digit relates to the specific adjudicator who completed the adjudication form.
version_formString100RecommendedForm usedvers
daysrzIntegerRecommendeddays since randomizationllaa0b, uvfa0b, visitdt
llaa1IntegerRecommendedIs the patient taking a lipid lowering agent?0;10=No; 1= Yes
llaa2IntegerRecommendedSince the last study visit, have there been any changes in the specific lipid-lowering agent the patient is taking or in the dose of that agent?0;10=No; 1= Yes
medication5_nameString100RecommendedName fifth medication that the participant has takenllaa3e, stnm5
medication6_nameString100RecommendedName sixth medication that the participant has takenllaa3f, stnm6
medication5_dosageString50RecommendedFifth medication dosagellaa4e1
medication6_dosageString50RecommendedSixth medication dosagellaa4f1
medication1_unitString100RecommendedUnits of medication #1:llaa4a2
medication2_unitString10RecommendedUnits of medication #2:llaa4b2
medication3_unitString10RecommendedUnits of medication #3:llaa4c2
medication4_unitString10RecommendedUnits of medication #4:llaa4d2
medication5_unitString10RecommendedUnits of medication #5:llaa4e2
medication6_unitString10RecommendedUnits of medication #6:llaa4f2
llaa5aIntegerRecommendedSince your last appointment, on how many days did you NOT TAKE medication #1?0::50; -999999=Legitimately skipped
llaa5bIntegerRecommendedSince your last appointment, on how many days did you NOT TAKE medication #2?0::50; -999999=Legitimately skipped
llaa5cIntegerRecommendedSince your last appointment, on how many days did you NOT TAKE medication #3?0::50; -999999=Legitimately skipped
llaa5dIntegerRecommendedSince your last appointment, on how many days did you NOT TAKE medication #4?0::50; -999999=Legitimately skipped
llaa5eIntegerRecommendedSince your last appointment, on how many days did you NOT TAKE medication #5?0::50; -999999=Legitimately skipped
llaa5fIntegerRecommendedSince your last appointment, on how many days did you NOT TAKE medication #6?0::50; -999999=Legitimately skipped
llaa6aIntegerRecommendedSince your last appointment, on how many days did you take MORE THAN or LESS THAN the prescribed dose of medication #1?0::50; -999999=Legitimately skipped
llaa6bIntegerRecommendedSince your last appointment, on how many days did you take MORE THAN or LESS THAN the prescribed dose of medication #2?0::50; -999999=Legitimately skipped
llaa6cIntegerRecommendedSince your last appointment, on how many days did you take MORE THAN or LESS THAN the prescribed dose of medication #3?0::50; -999999=Legitimately skipped
llaa6dIntegerRecommendedSince your last appointment, on how many days did you take MORE THAN or LESS THAN the prescribed dose of medication # 4?0::50; -999999=Legitimately skipped
llaa6eIntegerRecommendedSince your last appointment, on how many days did you take MORE THAN or LESS THAN the prescribed dose of medication #5?0::50; -999999=Legitimately skipped
llaa6fIntegerRecommendedSince your last appointment, on how many days did you take MORE THAN or LESS THAN the prescribed dose of medication #6?0::50; -999999=Legitimately skipped
llaa7aIntegerRecommendedBased on the clinician's best judgment, please indicate the patient's adherence to medication #1: (Choose one LLAA7A from A, B, C, D, or E below)1::5; 999999=Legitimately skipped
llaa7bIntegerRecommendedBased on the clinician's best judgment, please indicate the patient's adherence to the medication: (Choose one from A, B, C, D, or E below)1::5; 999999=Legitimately skipped
llaa7cIntegerRecommendedBased on the clinician's best judgment, please indicate the patient's adherence to medication #3: (Choose one from A, B, C, D, or E below)1::5; 999999=Legitimately skipped
llaa7dIntegerRecommendedBased on the clinician's best judgment, please indicate the patient's adherence to medication #4: (Choose one from A, B, C, D, or E below)1::5; 999999=Legitimately skipped
llaa7eIntegerRecommendedBased on the clinician's best judgment, please indicate the patient's adherence to medication #5: (Choose one from A, B, C, D, or E below)1::5; 999999=Legitimately skipped
llaa7fIntegerRecommendedBased on the clinician's best judgment, please indicate the patient's adherence to the medication: (Choose one from A, B, C, D, or E below)1::5; 999999=Legitimately skipped
studyString100RecommendedStudystudyid
siteString100RecommendedSiteStudy Sitesiteid
completedIntegerRecommendedChecks if form is completed0::20=No; 1=Yes; 2=Yes, lostformcomp
subtrial_nameIntegerRecommendedName of subtrial1::31=Crossover; 2=Guanfacine; 3= Open Label MPH
vis_q01IntegerRecommendedAttended visit?0::30=No; 1=Yes;2=Yes, visit form entered; 3=Yes, data collected - visit form added later
qccur_rFloatRecommendedQIDS-C current score (transcribed)qccur
hrsd_rFloatRecommendedHRS-D current score (transcribed)999=missinghrsdcur
atmtsuicIntegerRecommendedAttempted suicide0;10=No; 1=Yes
eeg012IntegerRecommendedWomen only: Still experiencing menstrual periods?0;1;90=No; 1=Yes; 9=N/Amenop_1
qcbeg_rFloatRecommendedQIDS-C beginning score (transcribed)
qcimp_rFloatRecommendedQIDS-C percent improvement (transcribed)
fibser_1IntegerRecommended1. Choose the response that best describes the frequency (how often) of the side effects of the medication you have taken within the past week for your depression.0::70=No side effects; 1=Present 10% of the time; 2=Present 25% of the time; 3=Present 5-% of the time; 4=Present 75% of the time; 5=Present 90% of the time; 6=Present all the time; 7=refusedfiserf, fiserfrg, fiserfrq
fibser_2IntegerRecommended2. Choose the response that best describes the intensity (how severe) of the side effects that you believe are due to the medication you have taken within the last week for your depression0::60=No side effects; 1=Trivial; 2=Mild; 3=Moderate; 4=Marked; 5=Severe; 6=Intolerablefideri, fiserint
fibser_3IntegerRecommended3. Choose the response that best describes the degree to which antidepressant medication side effects that you have had over the last week have interfered with your day to day functions.0::60=No impairment; 1=Minimal impairment; 2=Mild impairment; 3=Moderate impairment; 4=Marked impairment; 5=Severe impairment; 6=Unable to function due to side effectsgrseb
cgi_sii_0_7IntegerRecommendedCGI SII 0 - 7 Improvment/change0::7; 90 = Not assessed; 1 = Very much improved; 2 = Much improved; 3 = Minimally improved; 4 = No change; 5 = Minimally worse; 6 = Much worse; 7 = Very much worse; 9=NAcgi_i
maqIntegerRecommended0 = N/A, no prescribed meds;1 = Never missed;2 = Rarely;3 = Sometimes;4 = Less than half the time;5 = About half the time;6 = Somewhat more than half the time;7 = Very often;8 = Nearly all the time;9 = All the time
stmed_1IntegerRecommended0=No;1=Yes
stmd7IntegerRecommended
medication7_nameString100RecommendedName seventh medication that the participant has takenstnm7
stsd7IntegerRecommendedPrescribed med start date 7
sted7IntegerRecommended
stds7FloatRecommended
phaseIntegerRecommendedPhase9 =follow up
responseIntegerRecommended1 = NonResponse(<30% reduction in HRSD scores and HRSD >15 for 2 consecutive visits and met the DSM-IV criteria for MDD for 2 consecutive visits during weeks 6, 8, 10, and 12) 2 = Partial Response(not meeting criteria for NonResponse or Remission) 3 = Remission(>60% reduction in HRSD scores and HRSD <8 for 2 consecutive visits and does not meet DSM-IV criteria for MDD for 2 consecutive visits during weeks 6, 8, 10, and 12)If the patient meets the criteria for NonResponse the patient will advance to the Randomization Phase (Phase II). If the patient has had a partial response, continue at the maximum tolerated dose of the current medication up to week 12 then advance to the Randomization Phase. If the patient meets the criteria for Remission at week 12, continue on current medications in Phase II with patient visits scheduled only once every 4 weeks.
pharma_timeIntegerRecommendedtimetime
baseline_a_002String100RecommendedInterview Start Time:
minietmString10RecommendedTime interview ended
urt_q02String5RecommendedTime of last study med takenQ.2 Enter valid time using 24 hour clock in the following format: hh:mm; -888=NA
Data Structure

This page displays the data structure defined for the measure identified in the title and structure short name. The table below displays a list of data elements in this structure (also called variables) and the following information:

  • Element Name: This is the standard element name
  • Data Type: Which type of data this element is, e.g. String, Float, File location.
  • Size: If applicable, the character limit of this element
  • Required: This column displays whether the element is Required for valid submissions, Recommended for valid submissions, Conditional on other elements, or Optional
  • Description: A basic description
  • Value Range: Which values can appear validly in this element (case sensitive for strings)
  • Notes: Expanded description or notes on coding of values
  • Aliases: A list of currently supported Aliases (alternate element names)
  • For valid elements with shared data, on the far left is a Filter button you can use to view a summary of shared data for that element and apply a query filter to your Cart based on selected value ranges

At the top of this page you can also:

  • Use the search bar to filter the elements displayed. This will not filter on the Size of Required columns
  • Download a copy of this definition in CSV format
  • Download a blank CSV submission template prepopulated with the correct structure header rows ready to fill with subject records and upload

Please email the The NDA Help Desk with any questions.

Distribution for DataStructure: ccv01 and Element:
Chart Help

Filters enable researchers to view the data shared in NDA before applying for access or for selecting specific data for download or NDA Study assignment. For those with access to NDA shared data, you may select specific values to be included by selecting an individual bar chart item or by selecting a range of values (e.g. interview_age) using the "Add Range" button. Note that not all elements have appropriately distinct values like comments and subjectkey and are not available for filtering. Additionally, item level detail is not always provided by the research community as indicated by the number of null values given.

Filters for multiple data elements within a structure are supported. Selections across multiple data structures will be supported in a future version of NDA.